DarioHealth
DRIO
14 hedge funds and large institutions have $408K invested in DarioHealth in 2018 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 0 closing their positions.
36% more capital invested
Capital invested by funds: $300K → $408K (+$108K)
17% more funds holding
Funds holding: 12 → 14 (+2)
0% more ownership
Funds ownership: 0% → 0% (+0%)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$155K |
| 2 |
BlackRock
New York
|
+$34K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$30.7K |
| 4 |
VF
Virtu Financial
New York
|
+$10.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$11.8K |
| 2 |
PVH
Psagot Value Holdings
Tel Aviv,
Israel
|
-$10.5K |
| 3 |
BA
Bard Associates
Chicago,
Illinois
|
-$6.53K |
DRIO Hedge Fund Activity: Q2 2018 in Review
14 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in DarioHealth (DRIO) for Q2 2018, worth a combined $408K — up 36% from $300K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new DRIO positions and 0 closed out — a net gain of 2 holders — while 2 added to existing stakes and 3 trimmed.
The largest buyer was Vanguard Group, adding an estimated $155K. The largest seller was Susquehanna International Group, cutting an estimated $11.8K.
- 14 institutional investors held DarioHealth (DRIO) as of Q2 2018, up from 12 in Q1 2018.
- Funds reported $408K of DarioHealth stock for Q2 2018, up 36% quarter-over-quarter.
- 2 funds opened new DarioHealth positions in Q2 2018 and 0 closed out, a net change of +2 holders.
- The largest DarioHealth buyer in Q2 2018 was Vanguard Group, an estimated $155K added.
- The largest DarioHealth seller in Q2 2018 was Susquehanna International Group, an estimated $11.8K sold.
Based on aggregated 13F filings for Q2 2018.